In cancer research, innovation is often constrained by the tools designed to advance it. When those tools are expensive, complex, or difficult to maintain, progress slows. Researchers at NYU Abu Dhabi have introduced a solution that could remove a long-standing…
Vaccine manufacturers and public health experts are voicing strong concern after a U.S. advisory panel voted to end its long-standing recommendation that all newborns receive a hepatitis B vaccine at birth — a policy shift critics warn could erode decades…
China’s Sichuan Kelun-Biotech Biopharmaceutical has entered a major licensing agreement with U.S.-based Crescent Biopharma, granting the company global (ex-China) rights to develop and commercialise its experimental cancer therapy, SKB105. The deal, announced Thursday in Shanghai, includes an $80 million upfront…
At the Global Health Exhibition 2025 in Riyadh, U.S.-based Persivia Inc. introduced the National Health Intelligence Initiative, a major step toward Saudi Arabia’s data-driven healthcare transformation under Vision 2030. Far beyond a typical product launch, the initiative represents a strategic…
In a move that could reshape children’s healthcare across the Gulf, teams from Cincinnati Children’s Hospital—one of the top-ranked paediatric hospitals in the United States—are now working alongside doctors at Sheikh Khalifa Medical City (SKMC) in Abu Dhabi. The collaboration,…
